FIELD: medicine. SUBSTANCE: method involves recording electroencepalogram in the passive awareness state of a patient. Electroencepalogram fragments of duration not longer than 1 min showing no signs of paroxysmal activity are treated using cross-correlation analysis method. Alpha activity cross-correlation coefficient is calculated between leads from the left frontal and left occipital areas. The cross-correlation coefficient values being found within the limits from -1.00 to -0.35, healthy patient is considered to be the case. The value being between - 0.34 and 0.00, preclinical epilepsy stage is considered to be the case. The value being equal to 0.01 to 1.00, clinical epilepsy stage is considered to be the case. EFFECT: enhanced accuracy of diagnosis. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIAGNOSTICS AND PREDICTION OF EPILEPSY DEVELOPMENT IN PATIENTS AT PRECLINICAL STAGE OF THE DISEASE | 2001 |
|
RU2188575C1 |
METHOD FOR PREDICTING PRE-CLINICAL STAGE OF EPILEPSY | 2003 |
|
RU2246727C2 |
METHOD FOR DIAGNOSING THE CASES OF EPILEPSY AND ITS PRELIMINARY STAGE | 1999 |
|
RU2156607C1 |
METHOD OF DIAGNOSING AND TREATING PRECLINICAL EPILEPSY PHASE | 2003 |
|
RU2231363C1 |
METHOD FOR PREDICTING DIFFERENT STAGES OF EPILEPTOGENESIS | 2004 |
|
RU2297791C2 |
METHOD FOR PREDICTING REMISSION OF EPILEPSY | 2003 |
|
RU2238029C1 |
METHOD OF NEUROIMMUNE DISORDER DIAGNOSTICS | 2006 |
|
RU2329762C2 |
METHOD OF ESTIMATING SEVERITY DEGREE OF EPILEPSY COMPLICATED BY ORGANIC ENCELOPHATHY | 2009 |
|
RU2433784C2 |
METHOD FOR EVALUATING EPILEPSY PHARMACOTHERAPY EFFECTIVENESS | 2000 |
|
RU2164688C1 |
METHOD AND DEVICE FOR STUDYING FUNCTIONAL STATE OF BRAIN AND METHOD FOR MEASURING SUBELECTRODE RESISTANCE | 2003 |
|
RU2252692C2 |
Authors
Dates
2002-09-27—Published
2001-03-28—Filed